Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does EFAVIRENZ Cause Virologic failure? 916 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 916 reports of Virologic failure have been filed in association with EFAVIRENZ (Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate). This represents 11.6% of all adverse event reports for EFAVIRENZ.

916
Reports of Virologic failure with EFAVIRENZ
11.6%
of all EFAVIRENZ reports
20
Deaths
30
Hospitalizations

How Dangerous Is Virologic failure From EFAVIRENZ?

Of the 916 reports, 20 (2.2%) resulted in death, 30 (3.3%) required hospitalization, and 3 (0.3%) were considered life-threatening.

Is Virologic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for EFAVIRENZ. However, 916 reports have been filed with the FAERS database.

What Other Side Effects Does EFAVIRENZ Cause?

Foetal exposure during pregnancy (701) Drug resistance (654) Drug interaction (645) Viral mutation identified (641) Depression (602) Pathogen resistance (567) Maternal exposure during pregnancy (478) Treatment failure (390) Immune reconstitution inflammatory syndrome (301) Death (295)

What Other Drugs Cause Virologic failure?

LAMIVUDINE (1,894) TENOFOVIR DISOPROXIL (896) NEVIRAPINE (813) DOLUTEGRAVIR (770) ZIDOVUDINE (741) RITONAVIR (594) RALTEGRAVIR (517) ABACAVIR (490) LOPINAVIR\RITONAVIR (428) TENOFOVIR (409)

Which EFAVIRENZ Alternatives Have Lower Virologic failure Risk?

EFAVIRENZ vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL EFAVIRENZ vs EFAVIRENZ\LAMIVUDINE\TENOFOVIR DISOPROXIL EFAVIRENZ vs EFFEXOR EFAVIRENZ vs EFFIENT EFAVIRENZ vs EFGARTIGIMOD ALFA

Related Pages

EFAVIRENZ Full Profile All Virologic failure Reports All Drugs Causing Virologic failure EFAVIRENZ Demographics